American Journal of Gastroenterology

publication venue for

Efficacy and Safety of On-Demand Vonoprazan versus Placebo in the Treatment of Heartburn in Symptomatic Nonerosive Reflux Disease (NERD) Patients: A Phase 2 Randomized Controlled Trial 2022
Comparative Effectiveness of Biologics for Endoscopic Healing of the Ileum and Colon in Crohn's Disease 2022
Potential Modifiers and Different Cut-offs in Diagnostic Accuracy of Fecal Immunochemical Test in Detecting Advanced Colon Neoplasia: A Diagnostic Test Accuracy Meta-Analysis 2021
Understanding Patients' Perceptions of Fecal Microbiota Transplant 2019
2885 Reducing Anxiety in Patients Undergoing First-Time Colonoscopy: A Pilot and Feasibility Study for a Randomized Controlled Trial 2019
579 The Efficacy and Safety of Andexanet Alfa in Patients With Acute Gastrointestinal Bleeding While Taking Factor Xa Inhibitors: An ANNEXA-4 Sub-Analysis 2019
Beliefs and Practices of Canadian and US Physicians Regarding the Use of Probiotics for Gastrointestinal Illnesses 2018
Higher Adalimumab Maintenance Regimens Are More Effective Than Standard Maintenance Regimens in Crohnʼs Disease Patients Who Have Failed Infliximab 2017
A Meta-Analysis of Diagnostic Test Accuracy (DTA) of the Endoscopic Ultrasound (EUS) and Magnetic Resonance Cholangiopancreatography (MRCP) in Detecting Choledocholithiasis 2016
Canadian Study of Outcomes in Adalimumab Patients with Support for Adherence: Results from the COMPANION Study 2016
Outcomes of Second- and Third-LineTumor Necrosis Factor-Î± Antagonists in Inflammatory Bowel Disease 2016
Post Analysis of Polyps in 9 Short Bowel Syndrome Patients Treated with Teduglutide 2016
A National Survey and Needs Assessment on Choices of Therapeutic Agents for Chronic Idiopathic Constipation and Constipation Predominant Irritable Bowel Syndrome: A Canadian Perspective 2015
Effect of Antidepressants on Sleep in Functional Dyspepsia 2015
Evaluation of a Novel, Icon-Based Symptom Assessment Tool for Gastroenterology 2015
Mucosal Healing Is Associated With Improved Long-Term Outcomes in Ulcerative Colitis: A Systematic Review and Meta-analysis Presidential Poster 2015
Vedolizumab for Moderate to Severely Active Inflammatory Bowel Disease: A Multicenter U.S. Consortium 2015
Are Patients Hospitalized With Cirrhosis and Ascites Receiving Appropriate Diagnostic Paracentesis? 2014
Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids: A Systematic Review and Meta-Analysis 2014
Mucosal Features of Colonic Crohn’s Disease Determined by Confocal Laser Endomicroscopy (CLE): An Inter-observer Agreement Study 2014
Adalimumab versus Infliximab for the Treatment of Moderate-to-severe Ulcerative Colitis in Adult Patients with No Prior Anti-TNF Experience: An Indirect Comparison Meta-analysis 2013
An Audit of Fecal Occult Blood Testing in Hospital Inpatients 2013
Changes in Domperidone Prescribing Practices after a “Black Box” Warning: Are We Exposing Inpatients to Unnecessary Cardiac Risk? 2013
Double Guidewire Technique for the Prevention of Post-ERCP Pancreatitis (PEP): Cochrane Collaboration Meta-analysis of RCTs 2013
Peri-operative Anti-TNFα Treatment and Post-operative Complications in Patients with Inflammatory Bowel Disease: A Systematic Review and Meta-analysis 2013
Current Management Practices for Moderate-To-Severe Gastroesophageal Reflux Disease (GERD) in Canadian Primary Care Practice 2012
Early Routine Endoscopic Retrograde Cholangiopancreatography (ERCP) Strategy versus Early Conservative Management Strategy in Acute Gallstone Pancreatitis: A Cochrane Systematic Review and Meta-analysis Presidential Poster 2012
Electrosurgical Current for Endoscopic Biliary Sphincterotomy (EBS) for the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis (PEP): Cochrane Collaboration Meta-analysis of Randomized Controlled Trials 2012
Gluten Gambit: A Case of Hemophagocytic Lymphohistiocytic Syndrome and Enteropathy-Associated T-cell Lymphoma in a Patient with Refractory Celiac Disease 2012
Point Prevalence of Malnutrition Risk in a Tertiary Care Academic Hospital 2012
The Effect of After Hours Admission on Outcomes of Upper Gastrointestinal Bleeding 2012
Gender Differences in Psychologic Parameters in Functional Dyspepsia 2011
Determining the Optimum Outcome for Trials Evaluating Symptom Improvement in Functional Gastrointestinal Disorders 2010
Effect of Comorbidity on Mortality in Patients with Peptic Ulcer Bleeding - A Systematic Review and Meta-Analysis 2010
Quadruple Therapy Using a 3-in-1 Capsule of Bismuth Subcitrate Potassium, Metronidazole, and Tetracycline with Omeprazole Compared to Triple Therapy for the Eradication of Helicobacter pylori: 2010 Presidential Poster 2010
Rare Long Term Complication of “Push” Introducing Technique for PEG Tube Insertion 2010
Endoscopic Ultrasound (EUS) and Secretin Endoscopic Pancreatic Function Test (ePFT): Histopathological Correlation in Chronic Pancreatitis (CP) 2009 Presidential Poster 2009
Epidemiology of Blood Stream Infections in a Hospital-Based, Home Parenteral Nutrition Program 2009
Lactose Hydrogen Breath Test as a Screening Test for Small Intestinal Bacterial Overgrowth 2009
Use of Antisecretory Medication after Antireflux Surgery for Patients with Gastroesophageal Reflux Disease (GERD): A Systematic Review of Randomized Control Trials (RCTs) 2009
Assessing the Learning Curve for the Acquisition of Colonoscopy Skills on a Computer-Based Endoscopy Simulator 2008
Delayed Retroperitoneal Perforation in Patient on Immunosuppresive Treatment 2008
Efficacy of 5HT3-Antagonists in non-constipation predominant irritable bowel syndrome: systematic review and meta-analysis 2008
Efficacy of 5HT4-Agonists in Non-Diarrhea Predominant Irritable Bowel Syndrome 2008
Efficacy of Antidepressants in Irritable Bowel Syndrome 2008
Efficacy of a Probiotic Fermented Drink of Lactobacillus Acidophilus and Lactobacillus Casei in the Reduction of Antibiotic-Associated Diarrhea 2008
Efficacy of antispasmodics and peppermint oil in irritable bowel syndrome: Systematic review and meta-analysis 2008
Intragastric Acid Suppressing Effect of Proton Pump Inhibitors Twice Daily at Steady State in Healthy Volunteers 2008
Night-Time pH Holding Time 2008
The Efficacy of Probiotics in the Therapy of Irritable Bowel Syndrome (IBS) 2008
Triple Versus Quadruple Therapy as Primary Treatment for Heliobacter pylori Infection 2008
Utility of Diagnostic Tests for Celiac Disease in Irritable Bowel Syndrome 2008
Familial Aggregation of Functional Dyspepsia: A Case-Control Study 2007
Incidence of Endoscopic Gastric and Duodenal Ulcers (GDUs) in Randomized Placebo-Controlled NSAIDs Trials: A Meta-Analysis 2007
Is There a Difference in the Prevalence of Helicobacter pylori Infection between Short-Segment and Long-Segment Barrettʼs Esophagus? 2007
Leucocyte Esterase Reagent Strips for the Diagnosis of Spontaneous Bacterial Peritonitis: A Systematic Review 2007
The Role of cagE, oipA, cagA and vacA Genes of Helicobacter pylori in Iranian Dyspepsia Patients 2007
cag PAI in H. pylori Isolated from Dyspeptic Patients in Tehran, Iran 2007
AGN 201904-Z (AGN), a Novel Enteric-Coated PPI, Produces Greater, More Prolonged Acid Suppression Than Esomeprazole (ESO) in Healthy Male Volunteers 2006
Effect of Esomeprazole on Symptoms of Patients with Irritable Bowel Syndrome (IBS) and Functional Diarrhea (FD) 2006
Familial Aggregation of Functional Dyspepsia 2006
Further Characterization of Painful Functional Constipation (PFC) 2006
Oral Rabeprazole 20 Mg Provides More Effective Acid Control Than IV Pantoprazole 40 Mg 2006
An Algorithm Using CART Analysis To Identify IBS-C and IBS-A from IBS-D 2005
A PROSPECTIVE ASSESSMENT OF BOWEL HABIT IN IBS 2004
RANDOMIZED ACTIVE AND PLACEBO-CONTROLLED ENDOSCOPY STUDY EVALUATING A NOVEL PROTECTED FORMULATION OF ORAL ALENDRONATE 2004
Helicobacter pylori infection and Barrett?s esophagus: a meta-analysis 2003
Incidence of endoscopic gastroduodenal ulcers(GDUS) in the placebo arms in randomized controlled NSAIDs trials?a meta-analysis 2003
Non-selective nonsteroidal anti-inflammatory drugs (NSAIDs) and inflammatory bowel disease (IBD): a critical appraisal of the evidence 2003
After hours telephone calls from patients with functional or organic diagnoses. Do physician and patient perceptions differ? 2002
Cytomegalovirus infection in steroid-refractory ulcerative colitis 2002
High dose intravenous proton pump inhibitors (IV PPI) decrease hospital mortality in selected patients with upper gastrointestinal bleeding 2002
Non-Steroidal Anti-Inflammatory Drug (NSAID) use and prevention of Colorectal Cancer (CRC): a meta-analysis 2002
Patients' concerns regarding (GI) endoscopic procedures - Factor analysis and characteristics among patient groups 2002
Predictors of treatment response and relapse for heartburn-dominant uninvestigated dyspepsia (HBDUD) in primary care practice (PCP): the CADET-HR study 2002
Predictors of treatment response in patients with endoscopy-negative reflux disease (ENRD) 2002
The establishment of a parasitic infection model using trichinella spiralis in mongolian gerbils 2002
What predicts patients' difficulty and satisfaction associated with (GI) endoscopic procedures? 2002
MAGNIFICATION DUAL IMAGING VIDEOENDOSCOPY WITH COMPUTERIZED VIDEOENHANCEMENT - AN UNIQUE CLOSE-UP VIEW OF THE UPPER GASTROINTESTINAL-TRACT 1988
COLONOSCOPY OR BARIUM ENEMA - WHICH WOULD YOU RATHER 1987
THE EFFECT OF L-AMINO-ACIDS ON GASTRIC-ACID SECRETION IN HEALTHY-SUBJECTS AND PATIENTS WITH ALCOHOLIC CIRRHOSIS 1987
EARLY DIAGNOSIS OF COLORECTAL NEOPLASIA USING HEMOCCULT TESTING IN GENERAL-PRACTICE 1985
IMPORTANCE OF THE DIAPHRAGM IN PREVENTING GASTROESOPHAGEAL REFLUX DURING IMPEDED BREATHING 1985
H-2-RECEPTOR ANTAGONIST-ACETAMINOPHEN INTERACTIONS 1984
A COMPUTERIZED SYSTEM FOR COLONOSCOPY RECORDS 1983
Worldwide Prevalence and Description of Cyclic Vomiting Syndrome According to the Results of the Rome Foundation Global Epidemiology Study. 2024
Using Diet to Treat Inflammatory Bowel Disease: A Systematic Review 2024
Incidence, Predictors, and Outcomes of Clinically Significant Post-Endoscopic Retrograde Cholangiopancreatography Bleeding: A Contemporary Multicenter Study. 119:2317-2325. 2024
Delayed Ustekinumab and Adalimumab Responders Have Similar Outcomes as Early Responders in Biologic-Naïve Crohn's Disease. 119:1355-1364. 2024
Resolution of rectal bleeding by day 7 in acute severe ulcerative colitis is prognostic for post-discharge corticosteroid free clinical remission and endoscopic improvement. 119:1939-1942. 2024
Global Prevalence of Psychological Distress and Comorbidity With Disorders of Gut-Brain Interactions. 119:165-175. 2024
Continuing Medical Education Questions: November 2023. 118:1925-1925. 2023
Patients With Crohn's Disease and Permanent Ileostomy Are Universally Excluded From Clinical Trials: A Systematic Review. 118:1285-1288. 2023
Periprocedural Management of Patients With Atrial Fibrillation Receiving a Direct Oral Anticoagulant Undergoing a Digestive Endoscopy. 118:812-819. 2023
REMIT-UC: Real-World Effectiveness and Safety of Tofacitinib for Moderate-to-Severely Active Ulcerative Colitis. 118:861-871. 2023
The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium. 118:317-328. 2023
Working to Answer the Effectiveness of Nutrition in IBD: Still a Ways to Go. 118:256-258. 2023
Long-Term Outcomes of Early vs Delayed Responders to Vedolizumab and Adalimumab: A Post Hoc Analysis of the VARSITY Study. 118:121-128. 2023
Continuing Medical Education Questions: November 2022. 117:1741-1741. 2022
Association of Celiac Disease and Inflammatory Bowel Disease: A Nationwide Register-Based Cohort Study. 117:1471-1481. 2022
Mechanisms Underlying Food-Triggered Symptoms in Disorders of Gut-Brain Interactions. 117:937-946. 2022
American College of Gastroenterology-Canadian Association of Gastroenterology Clinical Practice Guideline: Management of Anticoagulants and Antiplatelets During Acute Gastrointestinal Bleeding and the Periendoscopic Period. 117:542-558. 2022
Management of Patients on Anticoagulants and Antiplatelets During Acute Gastrointestinal Bleeding and the Peri-Endoscopic Period: A Clinical Practice Guideline Dissemination Tool. 117:513-519. 2022
S326 Potential Modifiers and Different Cut-offs in Diagnostic Accuracy of Fecal Immunochemical Test in Detecting Advanced Colon Neoplasia: A Diagnostic Test Accuracy Meta-Analysis. 116:S141-S142. 2021
Correction to: Probiotics for Celiac Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. 116:1968-1968. 2021
A Microsimulation Model to Determine the Cost-Effectiveness of Treat-to-Target Strategies for Crohn's Disease. 116:1709-1719. 2021
Accuracy of Screening Tests for Celiac Disease in Asymptomatic Patients With Type 1 Diabetes. 116:1545-1549. 2021
Continuing Medical Education Questions: July 2021. 116:1380-1380. 2021
A Riddle, Wrapped in a Mystery, Inside an Enigma: Another Key to Wheat Sensitivity?. 116:943-945. 2021
Probiotics for Celiac Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. 115:1584-1595. 2020
S3200 ABP 710, a Biosimilar to Infliximab Reference Product: Supporting Extrapolation of Indications With a Focus on Crohn’s Disease. 115:S1678-S1679. 2020
Ileal and Rectal Ulcer Size Affects the Ability to Achieve Endoscopic Remission: A Post hoc Analysis of the SONIC Trial. 115:1236-1245. 2020
Incorporating Fecal Calprotectin Into Clinical Practice for Patients With Moderate-to-Severely Active Ulcerative Colitis Treated With Biologics or Small-Molecule Inhibitors. 115:885-894. 2020
No Association Linking Short-Term Proton Pump Inhibitor Use to Dementia: Systematic Review and Meta-analysis of Observational Studies. 115:671-678. 2020
Continuing Medical Education Questions: January 2020: Chronic Pancreatitis: Managing a Difficult Disease. 115:17-17. 2020
Continuing Medical Education Questions: June 2019. 114:861-861. 2019
Evolving Paradigms in the Diagnosis of Adult Patients With Celiac Disease. 114:854-857. 2019
Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium. 114:696-696. 2019
Prokinetics for Functional Dyspepsia: A Systematic Review and Meta-Analysis of Randomized Control Trials. 114:233-243. 2019
Continuing Medical Education Questions: January 2019. 114:15-15. 2019
Effect of Antidepressants and Psychological Therapies in Irritable Bowel Syndrome: An Updated Systematic Review and Meta-Analysis. 114:21-39. 2019
Beliefs and Practices of Canadian and U.S. Physicians Regarding the Use of Probiotics for Gastrointestinal Illnesses. 113:S253-S253. 2018
A Systematic Review and Meta-Analysis Evaluating the Efficacy of a Gluten-Free Diet and a Low FODMAPS Diet in Treating Symptoms of Irritable Bowel Syndrome. 113:1290-1300. 2018
Open: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium. 113:1345-1345. 2018
American College of Gastroenterology Monograph on Management of Irritable Bowel Syndrome. 113:1-18. 2018
Response to Marlicz et al. 113:781-781. 2018
Response to Hsu et al.. 113:143-143. 2018
Proton Pump Inhibitors and Dementia: Deciphering the Data. 112:1809-1811. 2017
Corrigendum: ACG and CAG Clinical Guideline: Management of Dyspepsia. 112:1484-1484. 2017
ACG and CAG Clinical Guideline: Management of Dyspepsia. 112:988-1013. 2017
Response to Georgopoulos et al.. 112:1169-1170. 2017
Polymorphisms of 5-HTT LPR and GNβ3 825C>T and Response to Antidepressant Treatment in Functional Dyspepsia: A Study from The Functional Dyspepsia Treatment Trial. 112:903-909. 2017
ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. 112:212-239. 2017
How to Interpret a Negative Study. 111:1506-1507. 2016
The Real-World Effectiveness and Safety of Vedolizumab for Moderate–Severe Crohn’s Disease: Results From the US VICTORY Consortium. 111:1147-1155. 2016
Systematic Review and Meta-Analysis: Infliximab or Cyclosporine as Rescue Therapy in Patients With Severe Ulcerative Colitis Refractory to Steroids. 111:477-491. 2016
Gluten Introduction, Breastfeeding, and Celiac Disease: Back to the Drawing Board. 111:12-14. 2016
The Light Shines on: American Journal of Gastroenterology 2015. 110:1638-1639. 2015
Should ESPGHAN Guidelines for Serologic Diagnosis of Celiac Disease be Used in Adults? A Prospective Analysis in an Adult Patient Cohort With High Pretest Probability. 110:1504-1505. 2015
Anxiety and Depression Increase in a Stepwise Manner in Parallel With Multiple FGIDs and Symptom Severity and Frequency. 110:1038-1048. 2015
Addendum: BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett’s Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. 110:943-943. 2015
BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia (vol 110, pg 662, 2015). 110:943-943. 2015
BOB CAT: a Large-Scale Review and Delphi Consensus for Management of Barrett’s Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia. 110:662-682. 2015
Lack of Utility of Symptoms and Signs at First Presentation as Predictors of Inflammatory Bowel Disease in Secondary Care. 110:716-724. 2015
Response to Atreja et al.. 110:346-347. 2015
Efficacy of Prebiotics, Probiotics, and Synbiotics in Irritable Bowel Syndrome and Chronic Idiopathic Constipation: Systematic Review and Meta-analysis. 109:1547-1561. 2014
Effect of Antidepressants and Psychological Therapies, Including Hypnotherapy, in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis. 109:1350-1365. 2014
The Effect of Fiber Supplementation on Irritable Bowel Syndrome: A Systematic Review and Meta-analysis. 109:1367-1374. 2014
American College of Gastroenterology Monograph on the Management of Irritable Bowel Syndrome and Chronic Idiopathic Constipation. 109:S2-S26. 2014
Risk of Upper Gastrointestinal Bleeding With Selective Serotonin Reuptake Inhibitors With or Without Concurrent NonSteroidal Anti-Inflammatory Use: A Systematic Review and Meta-Analysis. 109:811-819. 2014
Hyponatremia and Sodium Picosulfate Bowel Preparations in Older Adults. 109:686-694. 2014
Novel Role of the Serine Protease Inhibitor Elafin in Gluten-Related Disorders. 109:748-756. 2014
The Role of Endoscopic Retrograde Cholangiopancreatography in Acute Pancreatitis. 109:443-444. 2014
Editorial : PPIs and Recurrent C. difficile Infection: No Association?. 108:1802-1803. 2013
Navigating Long-Term Safety in Fecal Microbiota Transplantation. 108:1538-1538. 2013
Response to Nahon et al. and Marmo et al.. 108:1534-1535. 2013
Fecal Microbiota Transplantation for Clostridium difficile Infection: Systematic Review and Meta-Analysis. 108:500-508. 2013
Early Endoscopic Retrograde Cholangiopancreatography in Acute Biliary Pancreatitis. 108:450-450. 2013
Effect of Comorbidity on Mortality in Patients With Peptic Ulcer Bleeding: Systematic Review and Meta-Analysis. 108:331-345. 2013
Stoking the Flame: The American Journal of Gastroenterology 2013. 108:162-165. 2013
Acid-Suppressive Therapy With Esomeprazole for Relief of Unexplained Chest Pain in Primary Care: A Randomized, Double-Blind, Placebo-Controlled Trial. 108:56-64. 2013
Editorial: Differences in Intestinal Microbial Composition in Children With IBS—What Does It All Mean?. 107:1752-1754. 2012
Diagnosis, Characterization, and 3-Month Outcome After Detoxification of 39 Patients With Narcotic Bowel Syndrome. 107:1426-1440. 2012
The Digital Rectal Examination: A Multicenter Survey of Physicians' and Students' Perceptions and Practice Patterns. 107:1157-1163. 2012
Chronic Gastrointestinal Consequences of Acute Infectious Diarrhea: Evolving Concepts in Epidemiology and Pathogenesis. 107:981-989. 2012
Editorial: How Much Do PPIs Contribute to C. difficile Infections?. 107:1020-1021. 2012
Levofloxacin-Based Three-Antibiotic Regimen for H. pylori Eradication. 107:1106-1107. 2012
What's Hot in the Red Journal This Month. 107:961-963. 2012
Effect of Dyspepsia on Survival: A Longitudinal 10-Year Follow-Up Study. 107:912-921. 2012
Editorial: Irritable Bowel Syndrome and the Elusive Mast Cells. 107:727-729. 2012
Response to Doherty and Moss. 107:487-488. 2012
Response to Lieb and Toskes. 107:484-485. 2012
Efficacy of Oral vs. Topical, or Combined Oral and Topical 5-Aminosalicylates, in Ulcerative Colitis: Systematic Review and Meta-Analysis. 107:167-176. 2012
Response to Kayhan et al.. 107:321-322. 2012
Treatment of Hospitalized Adult Patients With Severe Ulcerative Colitis: Toronto Consensus Statements. 107:179-194. 2012
Once-Daily Dosing vs. Conventional Dosing Schedule of Mesalamine and Relapse of Quiescent Ulcerative Colitis: Systematic Review and Meta-Analysis. 106:2070-2077. 2011
Response to Atreja et al.. 106:2046-2046. 2011
Response to Yang et al.. 106:2044-2044. 2011
Characterization of Episodes of Irritable Bowel Syndrome Using Ecological Momentary Assessment. 106:1813-1820. 2011
Reply to Akobeng. 106:1857-1858. 2011
Bloating in Gastroparesis: Severity, Impact, and Associated Factors. 106:1492-1502. 2011
Proton Pump Inhibitors and Risk of Fracture: A Systematic Review and Meta-Analysis of Observational Studies. 106:1209-1218. 2011
Corrigendum: Antibiotic Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. 106:1014-1014. 2011
An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease. 106:S2-S25. 2011
Antibiotic Therapy in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. 106:661-673. 2011
Efficacy of 5-Aminosalicylates in Crohn's Disease: Systematic Review and Meta-Analysis. 106:617-629. 2011
Efficacy of 5-Aminosalicylates in Ulcerative Colitis: Systematic Review and Meta-Analysis. 106:601-616. 2011
Efficacy of Biological Therapies in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis. 106:644-659. 2011
Efficacy of Immunosuppressive Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. 106:630-642. 2011
Glucocorticosteroid Therapy in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis. 106:590-599. 2011
5-Aminosalicylates Prevent Relapse of Crohn's Disease After Surgically Induced Remission: Systematic Review and Meta-Analysis. 106:413-420. 2011
Can Gluten Contribute to Irritable Bowel Syndrome?. 106:516-518. 2011
Corrigendum: Prevention Measures and Exploratory Pharmacological Treatments of Celiac Disease. 106:375-375. 2011
Prevention Measures and Exploratory Pharmacological Treatments of Celiac Disease. 105:2551-2561. 2010
What's Hot in the Red Journal. 105:2517-2519. 2010
Endoscopic Ultrasound, Secretin Endoscopic Pancreatic Function Test, and Histology: Correlation in Chronic Pancreatitis. 105:2498-2503. 2010
Psychological Dysfunction Is Associated With Symptom Severity but Not Disease Etiology or Degree of Gastric Retention in Patients With Gastroparesis. 105:2357-2367. 2010
The Gain in Quality-Adjusted Life Months by Switching to Esomeprazole in Those With Continued Reflux Symptoms in Primary Care: EncomPASS—A Cluster-Randomized Trial. 105:2341-2346. 2010
Colorectal and Rectocolonic Reflexes in Canines: Involvement of Tone, Compliance and Anal Sphincter Relaxation. 105:S129-S129. 2010
Gastric Electrical Stimulation Reduces Visceral Sensitivity to Gastric Distention in Healthy Canines. 105:S30-S31. 2010
A Specialized, Nurse-Run Titration Clinic: A Feasible Option for Optimizing β-Blockade in Non–Clinical Trial Patients. 105:1917-1921. 2010
Response to Doherty, Moss, and Cheifetz. 105:2111-2112. 2010
Measuring Quality of Care in Patients With Nonvariceal Upper Gastrointestinal Hemorrhage: Development of an Explicit Quality Indicator Set. 105:1710-1718. 2010
Response to Cappell. 105:1901-1902. 2010
Capsule Endoscopy Has a Significantly Higher Diagnostic Yield in Patients With Suspected and Established Small-Bowel Crohn's Disease: A Meta-Analysis. 105:1240-1248. 2010
Cognitive Factors Affect Treatment Response to Medical and Psychological Treatments in Functional Bowel Disorders. 105:1397-1406. 2010
Is There an Increased Risk of GERD After Helicobacter pylori Eradication?: A Meta-Analysis. 105:1007-1013. 2010
An Outbreak of Acute Bacterial Gastroenteritis Is Associated With an Increased Incidence of Irritable Bowel Syndrome in Children. 105:933-939. 2010
Impact of Functional Gastrointestinal Disorders on Survival in the Community. 105:822-832. 2010
Methodology for Randomized Trials of Patients With Nonvariceal Upper Gastrointestinal Bleeding: Recommendations From an International Consensus Conference. 105:540-550. 2010
Errors in the Conduct of Systematic Reviews of Pharmacological Interventions for Irritable Bowel Syndrome. 105:280-288. 2010
Empiric Quadruple vs. Triple Therapy for Primary Treatment of Helicobacter pylori Infection: Systematic Review and Meta-Analysis of Efficacy and Tolerability. 105:65-73. 2010
Passing the Torch: The American Journal of Gastroenterology 2010. 105:4-7. 2010
Response to Ball et al.. 105:223-224. 2010
Management of Platelet-Directed Pharmacotherapy in Patients With Atherosclerotic Coronary Artery Disease Undergoing Elective Endoscopic Gastrointestinal Procedures. 104:2903-2917. 2009
Sequential Therapy for Eradication of Helicobacter pylori: A New Guiding Light or a False Dawn?. 104:3081-3083. 2009
Response to Fuccio et al.. 104:2853-2854. 2009
Development and Validation of a Risk Score for Post-Infectious Irritable Bowel Syndrome. 104:2267-2274. 2009
Peginterferon Plus Ribavirin for Chronic Hepatitis C in Patients With Human Immunodeficiency Virus. 104:2335-2341. 2009
Efficacy of 5-HT3 Antagonists and 5-HT4 Agonists in Irritable Bowel Syndrome: Systematic Review and Meta-Analysis. 104:1831-1843. 2009
Between Celiac Disease and Irritable Bowel Syndrome: The “No Man's Land” of Gluten Sensitivity. 104:1587-1594. 2009
Systematic Reviews: The Good, the Bad and the Ugly. 104:1086-1092. 2009
An Evidence-Based Position Statement on the Management of Irritable Bowel Syndrome (vol 104, pg S1, 2009). 104:1072-1072. 2009
Helicobacter pylori Infection and Barrett's Esophagus: A Systematic Review and Meta-Analysis. 104:492-500. 2009
Non-Variceal Upper GI Bleeding in Patients Already Hospitalized for Another Condition. 104:330-339. 2009
An Evidence-Based Position Statement on the Management of Irritable Bowel Syndrome. 104:S1-S35. 2009
A BALANCING VIEW: Evidence-Based Medicine: Neither Savior Nor Scourge but a Practical Tool for Clinical Practice. 103:2969-2971. 2008
CON: Evidence-Based Medicine-The Emperor's New Clothes?. 103:2967-2969. 2008
Pro: EBM: an invaluable tool for medical practice.. 103:2965-2967. 2008
Optimizing Surveillance in Barrett's Esophagus: Response to Ruggeet al.. 103:2946-2947. 2008
Hip Fracture and Proton Pump Inhibitor Therapy: Balancing the Evidence for Benefit and Harm. 103:2428-2431. 2008
How Strong Is the Evidence?. 103:1334-1338. 2008
Irritable Bowel Syndrome: A 10-Yr Natural History of Symptoms and Factors That Influence Consultation Behavior. 103:1229-1239. 2008
Management of Barrett's Esophagus in the UK: Overtreated and Underbiopsied but Improved by the Introduction of a National Randomized Trial. 103:1079-1089. 2008
Gastric Cancer Consensus Conference RecommendsHelicobacter pyloriScreening and Treatment in Asymptomatic Persons From High-Risk Populations to Prevent Gastric Cancer. 103:510-514. 2008
Barrett's Esophagus and Obesity: The Missing Part of the Puzzle. 103:301-303. 2008
Detection of Intestinal Metaplasia in Barrett's Esophagus. 102:2353-2354. 2007
Impact of Asian Race on Response to Combination Therapy With Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C. 102:2181-2188. 2007
Systematic Review of the Risk of Enteric Infection in Patients Taking Acid Suppression. 102:2047-2056. 2007
What Patients Know About Irritable Bowel Syndrome (IBS) and What They Would Like to Know. National Survey on Patient Educational Needs in IBS and Development and Validation of the Patient Educational Needs Questionnaire (PEQ). 102:1972-1982. 2007
The Association Between Helicobacter pylori Infection and Early Gastric Cancer: A Meta-Analysis. 102:1789-1798. 2007
Characterization of Health Related Quality of Life (HRQOL) for Patients With Functional Bowel Disorder (FBD) and Its Response to Treatment. 102:1442-1453. 2007
Detection of Intestinal Metaplasia in Barrett's Esophagus: An Observational Comparator Study Suggests the Need for a Minimum of Eight Biopsies. 102:1154-1161. 2007
Who Consults With Dyspepsia? Results from a Longitudinal 10-Yr Follow-Up Study. 102:957-965. 2007
International Comparisons of Manpower in Gastroenterology. 102:478-481. 2007
Response to Dr. Zappa and Colleagues. 101:2433-2434. 2006
To establish the efficacy of PPI therapy for ulcer bleeding in the United States, do we need more patients or more PPI? (vol 101, pg 2000, 2006). 101:2445-2445. 2006
Esomeprazole 40 mg Once a Day in Patients with Functional Dyspepsia: The Randomized, Placebo-Controlled “ENTER” Trial. 101:2096-2106. 2006
To Establish the Efficacy of PPI Therapy for Ulcer Bleeding in the United States, Do We Need More Patients or More PPIs?. 101:2000-2002. 2006
The Montreal Definition and Classification of Gastroesophageal Reflux Disease: A Global Evidence-Based Consensus. 101:1900-1920. 2006
The Effect of CYP2C19 Polymorphisms on H. pylori Eradication Rate in Dual and Triple First-Line PPI Therapies: A Meta-analysis. 101:1467-1475. 2006
A Meta-Analysis of the Yield of Capsule Endoscopy Compared to Other Diagnostic Modalities in Patients with Non-Stricturing Small Bowel Crohn's Disease. 101:954-964. 2006
Colorectal Cancer Screening with Fecal Occult Blood Testing (FOBT): An International Perspective. 101:212-212. 2006
Does Fecal Occult Blood Testing Really Reduce Mortality? A Reanalysis of Systematic Review Data. 101:380-384. 2006
Fiber for the Treatment of Hemorrhoids Complications: A Systematic Review and Meta-Analysis. 101:181-188. 2006
Fiber for the treatment of hemorrhoids complications:: A systematic review and meta-analysis. 101:181-188. 2006
A Meta-Analysis of the Yield of Capsule Endoscopy Compared to Other Diagnostic Modalities in Patients with Obscure Gastrointestinal Bleeding. 100:2407-2418. 2005
Dysregulation of Peripheral Cytokine Production in Irritable Bowel Syndrome. 100:2517-2518. 2005
Effect on Intragastric pH of a PPI with a Prolonged Plasma Half-Life: Comparison between Tenatoprazole and Esomeprazole on the Duration of Acid Suppression in Healthy Male Volunteers. 100:1949-1956. 2005
Helicobacter pylori Eradication Has the Potential to Prevent Gastric Cancer: A State-of-the-Art Critique. 100:2100-2115. 2005
Response to "Potentially Flawed Interpretation of Data by Andriulli et al.". 100:2133-2133. 2005
A Randomized Trial Comparing Omeprazole, Ranitidine, Cisapride, or Placebo in Helicobacter pylori Negative, Primary Care Patients with Dyspepsia: The CADET-HN Study. 100:1477-1488. 2005
Diagnostic and Therapeutic Use of Proton Pump Inhibitors in Non-Cardiac Chest Pain: A Metaanalysis. 100:1226-1232. 2005
Clinical Response to Tricyclic Antidepressants in Functional Bowel Disorders is not Related to Dosage. 100:664-671. 2005
Gambling with Gastroesophageal Reflux Disease: Should We Worry about the QALY?. 100:534-536. 2005
Role of Supplemental Calcium in the Recurrence of Colorectal Adenomas: A Metaanalysis of Randomized Controlled Trials. 100:390-394. 2005
Symptom-Based Outcome Measures for Dyspepsia and GERD Trials: A Systematic Review. 100:442-452. 2005
Measuring Gastroesophageal Reflux Symptoms: Musings from Marrakech. 100:19-20. 2005
Measuring gastroesophageal reflux symptoms: musings from Marrakech.. 100:19-20. 2005
CON: Patients with GERD Should Be Screened Once at Least for Barrett's Esophagus-Medicine or Magic?. 99:2293-2295. 2004
Meta-analysis: Can We Mix Apples and Oranges?. 99:2297-2301. 2004
TREATMENT RESPONSE IN FUNCTIONAL BOWEL DISORDERS (FBD) IS PREDICTED BY CHANGES IN BOTH PHYSIOLOGICAL AND PSYCHOSOCIAL FACTORS. 99:s286. 2004
A Systematic Review of Psychological Therapies for Nonulcer Dyspepsia. 99:1817-1822. 2004
Eradication Therapy in Helicobacter pylori Positive Peptic Ulcer Disease: Systematic Review and Economic Analysis. 99:1833-1855. 2004
Prospective Comparison of Small Bowel Meal with Pneumocolon versus Ileo-Colonoscopy for the Diagnosis of Ileal Crohn's Disease. 99:1321-1329. 2004
The Canadian Registry on Nonvariceal Upper Gastrointestinal Bleeding and Endoscopy (RUGBE): Endoscopic Hemostasis and Proton Pump Inhibition are Associated with Improved Outcomes in a Real-Life Setting. 99:1238-1246. 2004
Alternative Medicine Use by Canadian Ambulatory Gastroenterology Patients: Secular Trend or Epidemic?. 99:319-326. 2004
An Update of The Cochrane Systematic Review of Helicobacter Pylori Eradication Therapy in Nonulcer Dyspepsia: Resolving The Discrepancy Between Systematic Reviews. 98:2621-2626. 2003
An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews.. 98:2621-2626. 2003
INCIDENCE OF POST-INFECTIOUS IRRITABLE BOWEL SYNDROME (PI-IBS) FOLLOWING A FOOD-BORNE OUTBREAK OF ACUTE GASTROENTERITIS ATTRIBUTED TO A VIRAL PATHOGEN. 98:S270-S270. 2003
The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events. 98:1725-1733. 2003
The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events. 98:1725-1733. 2003
Bismuth-Based Quadruple Therapy Using a Single Capsule of Bismuth Biskalcitrate, Metronidazole, and Tetracycline Given With Omeprazole Versus Omeprazole, Amoxicillin, and Clarithromycin for Eradication of Helicobacter pylori in Duodenal Ulcer Patients: a Prospective, Randomized, Multicenter, North American Trial. 98:562-567. 2003
Gastral Antral Biopsy in the Differentiation of Pediatric Colitides. 98:557-561. 2003
Gastral antral biopsy in the differentiation of pediatric colitides. 98:557-561. 2003
Correlation between clinical severity score and the lower esophageal sphincter relaxation pressure in idiopathic achalasia. 98:278-283. 2003
Use and misuse of cost-effectiveness terminology in the gastroenterology literature: a systematic review. 97:172-179. 2002
Use and misuse of cost-effectiveness terminology in the gastroenterology literature: a systematic review. 97:172-179. 2002
Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.. 96:2849-2857. 2001
Smoking and inflammatory bowel disease: an effect of disease or disease location: a meta-analysis. 96:S290-S290. 2001
Health-related quality of life in chronic liver disease: the impact of type and severity of disease. 96:2199-2205. 2001
Health-related quality of life in chronic liver disease: the impact of type and severity of disease. 96:2199-2205. 2001
Assessment of Utilities and Health-Related Quality of Life in Patients With Chronic Liver Disease. 96:579-583. 2001
Low Mortality in Ulcerative Colitis and Crohn's Disease in Three Regional Centers in England. 96:501-507. 2001
Re: Ammonia cannot explain the effect of H-pylori on omeprazole-induced acid suppression - Response to Dr. McColl et al.. 96:602-604. 2001
Response To Dr. Mccoll et al.. 96:602-604. 2001
Putting Rectal 5-Aminosalicylic Acid in Its Place: The Role in Distal Ulcerative Colitis. 95:1628-1636. 2000
Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis. 95:1628-1636. 2000
Assessment of gastric emptying using a low fat meal: establishment of international control values. 95:1456-1462. 2000
The proportion of upper gastrointestinal symptoms in the community associated with helicobacter pylori, lifestyle factors, and nonsteroidal anti-inflammatory drugs. 95:1448-1455. 2000
Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire. 95:999-1007. 2000
The effect of ammonia on omeprazole-induced reduction of gastric acidity in subjects with Helicobacter pylori infection. 95:947-955. 2000
What determines severity among patients with painful functional bowel disorders?. 95:974-980. 2000
Cholestatic Liver Diseases and Health-Related Quality of Life. 95:497-502. 2000
Marked Elevation of Serum Transaminases May Be Associated With Ovarian Hyperstimulation Syndrome. 94:3373-3373. 1999
The Usefulness of The Likelihood Ratio in The Diagnosis of Dyspepsia and Gastroesophageal Reflux Disease. 94:3122-3125. 1999
Prediction of Resource Utilization and Case Cost for Acute Nonvariceal Upper Gastrointestinal Hemorrhage at A Canadian Community Hospital. 94:1841-1846. 1999
Correspondence. 94:1108-1109. 1999
Cost and Cost-Effectiveness: Consistent Terminology Is Needed. 94:1108-1109. 1999
Guidelines for the management of Helicobacter pylori infection. 93:2330-2338. 1998
Quality-of-Life Assessments and Chronic Liver Disease. 93:1037-1041. 1998
Adding Once-Daily Omeprazole 20 mg to Metronidazole/Amoxicillin Treatment for Helicobacter pylori Gastritis: A Randomized, Double-Blind Trial Showing the Importance of Metronidazole Resistance. 93:5-10. 1998
Efficacy of omeprazole one year after cure of Helicobacter pylori infection in duodenal ulcer patients.. 92:576-581. 1997
Optimizing the pharmacology of acid control in acid-related disorders - Panel discussion. 92:S20-S21. 1997
Peptic ulcer disease: Defining the treatment strategies in the era of Helicobacter pylori. 92:S36-S40. 1997
Peptic ulcer disease: Defining the treatment strategies in the era of Helicobacter pylori - Panel discussion. 92:S41-S43. 1997
Peptic ulcer disease: defining the treatment strategies in the era of Helicobacter pylori.. 92:36S-40S. 1997
Ulcerogenesis: Integrating the roles of Helicobacter pylori and acid secretion in duodenal ulcer - Panel discussion. 92:S14-S16. 1997
The Short Inflammatory Bowel Disease Questionnaire: a quality of life instrument for community physicians managing inflammatory bowel disease. CCRPT Investigators. Canadian Crohn's Relapse Prevention Trial.. 91:1571-1578. 1996
Multiple submucosal ileal lipomas.. 90:503-504. 1995
Aspects of the theoretical basis and clinical relevance of low acid states.. 89:308-318. 1994
pH and Hp--gastric acid secretion and Helicobacter pylori: implications for ulcer healing and eradication of the organism.. 88:481-483. 1993
Meta-analysis of the efficacy of antibiotic therapy in eradicating Helicobacter pylori.. 87:1716-1727. 1992
Safety and efficacy of high kV biliary lithotripsy: preliminary experience.. 87:1744-1746. 1992
The effect of acupuncture on gastrointestinal function and disorders.. 87:1372-1381. 1992
14C-urea breath test for the detection of Helicobacter pylori.. 85:399-403. 1990
C-14 UREA BREATH TEST FOR THE DETECTION OF HELICOBACTER-PYLORI. 85:399-403. 1990
Media for the culture of Campylobacter pylori.. 84:79. 1989
Acid suppression and ulcer healing: dichotomy, degree, and dilemma.. 83:964-966. 1988
Combination of pirenzepine and cimetidine in the therapy of duodenal ulcer.. 83:891-892. 1988
Adenomyoma of the common bile duct.. 83:432-434. 1988
Pharmacokinetics and pharmacodynamics of treatments for peptic ulcer disease in the elderly.. 83:211-215. 1988
Reversibility of increased intestinal permeability to 51Cr-EDTA in patients with gastrointestinal inflammatory diseases.. 82:1159-1164. 1987
A double-blind randomized study comparing different dose regimens of H2-receptor antagonists on 24-hour gastric secretion in normal subjects and duodenal ulcer patients.. 82:36-41. 1987
The 24 hour profile of intragastric PH bacterial flora and concentrations of nitrite and nitrosocompounds during cimetidine treatment. 76:180. 1981

American Journal of Gastroenterology Journal

Overview

publication venue for

has subject area

Identity

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)